144 related articles for article (PubMed ID: 27480442)
1. Evaluation of Organogel Nanoparticles as Drug Delivery System for Lipophilic Compounds.
Martin B; Brouillet F; Franceschi S; Perez E
AAPS PharmSciTech; 2017 May; 18(4):1261-1269. PubMed ID: 27480442
[TBL] [Abstract][Full Text] [Related]
2. Aqueous dispersions of organogel nanoparticles - potential systems for cosmetic and dermo-cosmetic applications.
Kirilov P; Rum S; Gilbert E; Roussel L; Salmon D; Abdayem R; Serre C; Villa C; Haftek M; Falson F; Pirot F
Int J Cosmet Sci; 2014 Aug; 36(4):336-46. PubMed ID: 24749969
[TBL] [Abstract][Full Text] [Related]
3. Organogel Nanoparticles as a New Way to Improve Oral Bioavailability of Poorly Soluble Compounds.
Martin B; Garrait G; Beyssac E; Goudouneche D; Perez E; Franceschi S
Pharm Res; 2020 May; 37(6):92. PubMed ID: 32394200
[TBL] [Abstract][Full Text] [Related]
4. Gelled oil particles: a new approach to encapsulate a hydrophobic metallophthalocyanine.
Siqueira-Moura MP; Franceschi-Messant S; Blanzat M; Ré MI; Perez E; Rico-Lattes I; Lattes A; Tedesco AC
J Colloid Interface Sci; 2013 Jul; 401():155-60. PubMed ID: 23618324
[TBL] [Abstract][Full Text] [Related]
5. Development of highly stable colloidal dispersions of gelled-oil nanoparticles loaded with cuminaldehyde.
Ghiasi F; Eskandari MH; Golmakani MT; Hosseini SMH
J Colloid Interface Sci; 2019 Apr; 541():65-74. PubMed ID: 30682594
[TBL] [Abstract][Full Text] [Related]
6. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of biocompatible stabilised gelled soya bean oil nanoparticles as new hydrophobic reservoirs.
Boudier A; Kirilov P; Franceschi-Messant S; Belkhelfa H; Hadioui L; Roques C; Perez E; Rico-Lattes I
J Microencapsul; 2010; 27(8):682-92. PubMed ID: 20690792
[TBL] [Abstract][Full Text] [Related]
8. Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers. II. Evaluation of the imidazole antifungal drug-loaded nanoparticle dispersions and their gel formulations.
Das S; Ng WK; Tan RB
Nanotechnology; 2014 Mar; 25(10):105102. PubMed ID: 24531828
[TBL] [Abstract][Full Text] [Related]
9. Core-shell structured gel-nanocarriers for sustained drug release and enhanced antitumor effect.
He W; Lv Y; Zhao Y; Xu C; Jin Z; Qin C; Yin L
Int J Pharm; 2015 Apr; 484(1-2):163-71. PubMed ID: 25724136
[TBL] [Abstract][Full Text] [Related]
10. Development and characterization of gel-in-water nanoemulsion as a novel drug delivery system.
Fardous J; Omoso Y; Joshi A; Yoshida K; Patwary MKA; Ono F; Ijima H
Mater Sci Eng C Mater Biol Appl; 2021 May; 124():112076. PubMed ID: 33947568
[TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid.
Jhawat V; Gupta S; Saini V
Drug Deliv; 2016 Nov; 23(9):3573-3581. PubMed ID: 27494650
[TBL] [Abstract][Full Text] [Related]
12. Design of an Inflammation-Sensitive Polyelectrolyte-Based Topical Drug Delivery System for Arthritis.
Bijukumar D; Choonara YE; Murugan K; Choonara BF; Kumar P; du Toit LC; Pillay V
AAPS PharmSciTech; 2016 Oct; 17(5):1075-85. PubMed ID: 26515798
[TBL] [Abstract][Full Text] [Related]
13. Characterization of organogel as a novel oral controlled release formulation for lipophilic compounds.
Iwanaga K; Sumizawa T; Miyazaki M; Kakemi M
Int J Pharm; 2010 Mar; 388(1-2):123-8. PubMed ID: 20045041
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for the controlled delivery of poorly water soluble non-steroidal anti-inflammatory drugs.
Kumar R; Singh A; Garg N; Siril PF
Ultrason Sonochem; 2018 Jan; 40(Pt A):686-696. PubMed ID: 28946474
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the erosion rate and the drug release kinetics from organogels designed as matrices for oral controlled release of a hydrophobic drug.
Pereira Camelo SR; Franceschi S; Perez E; Girod Fullana S; Ré MI
Drug Dev Ind Pharm; 2016; 42(6):985-97. PubMed ID: 26548427
[TBL] [Abstract][Full Text] [Related]
16. Characterization of gelation process and drug release profile of thermosensitive liquid lecithin/poloxamer 407 based gels as carriers for percutaneous delivery of ibuprofen.
Djekic L; Krajisnik D; Martinovic M; Djordjevic D; Primorac M
Int J Pharm; 2015 Jul; 490(1-2):180-9. PubMed ID: 26002567
[TBL] [Abstract][Full Text] [Related]
17. Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles.
Główka E; Wosicka-Frąckowiak H; Hyla K; Stefanowska J; Jastrzębska K; Klapiszewski Ł; Jesionowski T; Cal K
Eur J Pharm Biopharm; 2014 Sep; 88(1):75-84. PubMed ID: 25014763
[TBL] [Abstract][Full Text] [Related]
18. Transungual Delivery of Ketoconazole Nanoemulgel for the Effective Management of Onychomycosis.
Mahtab A; Anwar M; Mallick N; Naz Z; Jain GK; Ahmad FJ
AAPS PharmSciTech; 2016 Dec; 17(6):1477-1490. PubMed ID: 26857516
[TBL] [Abstract][Full Text] [Related]
19. Development and Optimisation of Spironolactone Nanoparticles for Enhanced Dissolution Rates and Stability.
Kelidari HR; Saeedi M; Akbari J; Morteza-Semnani K; Valizadeh H; Maniruzzaman M; Farmoudeh A; Nokhodchi A
AAPS PharmSciTech; 2017 Jul; 18(5):1469-1474. PubMed ID: 27834054
[TBL] [Abstract][Full Text] [Related]
20. Polycaprolactone Based Nanoparticles Loaded with Indomethacin for Anti-Inflammatory Therapy: From Preparation to Ex Vivo Study.
Badri W; Miladi K; Robin S; Viennet C; Nazari QA; Agusti G; Fessi H; Elaissari A
Pharm Res; 2017 Sep; 34(9):1773-1783. PubMed ID: 28527126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]